BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30765867)

  • 1. Nonsense variants in STAG2 result in distinct sex-dependent phenotypes.
    Aoi H; Lei M; Mizuguchi T; Nishioka N; Goto T; Miyama S; Suzuki T; Iwama K; Uchiyama Y; Mitsuhashi S; Itakura A; Takeda S; Matsumoto N
    J Hum Genet; 2019 May; 64(5):487-492. PubMed ID: 30765867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsense variants of
    Aoi H; Lei M; Mizuguchi T; Nishioka N; Goto T; Miyama S; Suzuki T; Iwama K; Uchiyama Y; Mitsuhashi S; Itakura A; Takeda S; Matsumoto N
    Hum Genome Var; 2020; 7():26. PubMed ID: 33014403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in STAG2 cause an X-linked cohesinopathy associated with undergrowth, developmental delay, and dysmorphia: Expanding the phenotype in males.
    Mullegama SV; Klein SD; Signer RH; ; Vilain E; Martinez-Agosto JA
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00501. PubMed ID: 30447054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo loss-of-function variants in STAG2 are associated with developmental delay, microcephaly, and congenital anomalies.
    Mullegama SV; Klein SD; Mulatinho MV; Senaratne TN; Singh K; ; Nguyen DC; Gallant NM; Strom SP; Ghahremani S; Rao NP; Martinez-Agosto JA
    Am J Med Genet A; 2017 May; 173(5):1319-1327. PubMed ID: 28296084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intact Cohesion, Anaphase, and Chromosome Segregation in Human Cells Harboring Tumor-Derived Mutations in STAG2.
    Kim JS; He X; Orr B; Wutz G; Hill V; Peters JM; Compton DA; Waldman T
    PLoS Genet; 2016 Feb; 12(2):e1005865. PubMed ID: 26871722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xq25 duplications encompassing GRIA3 and STAG2 genes in two families convey recognizable X-linked intellectual disability with distinctive facial appearance.
    Philippe A; Malan V; Jacquemont ML; Boddaert N; Bonnefont JP; Odent S; Munnich A; Colleaux L; Cormier-Daire V
    Am J Med Genet A; 2013 Jun; 161A(6):1370-5. PubMed ID: 23637084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent truncating mutations of STAG2 in bladder cancer.
    Solomon DA; Kim JS; Bondaruk J; Shariat SF; Wang ZF; Elkahloun AG; Ozawa T; Gerard J; Zhuang D; Zhang S; Navai N; Siefker-Radtke A; Phillips JJ; Robinson BD; Rubin MA; Volkmer B; Hautmann R; Küfer R; Hogendoorn PC; Netto G; Theodorescu D; James CD; Czerniak B; Miettinen M; Waldman T
    Nat Genet; 2013 Dec; 45(12):1428-30. PubMed ID: 24121789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microduplication of chromosome Xq25 encompassing STAG2 gene in a boy with intellectual disability.
    Yingjun X; Wen T; Yujian L; Lingling X; Huimin H; Qun F; Junhong C
    Eur J Med Genet; 2015 Feb; 58(2):116-21. PubMed ID: 25450604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo variants in CDK13 associated with syndromic ID/DD: Molecular and clinical delineation of 15 individuals and a further review.
    van den Akker WMR; Brummelman I; Martis LM; Timmermans RN; Pfundt R; Kleefstra T; Willemsen MH; Gerkes EH; Herkert JC; van Essen AJ; Rump P; Vansenne F; Terhal PA; van Haelst MM; Cristian I; Turner CE; Cho MT; Begtrup A; Willaert R; Fassi E; van Gassen KLI; Stegmann APA; de Vries BBA; Schuurs-Hoeijmakers JHM
    Clin Genet; 2018 May; 93(5):1000-1007. PubMed ID: 29393965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome.
    Clayton-Smith J; O'Sullivan J; Daly S; Bhaskar S; Day R; Anderson B; Voss AK; Thomas T; Biesecker LG; Smith P; Fryer A; Chandler KE; Kerr B; Tassabehji M; Lynch SA; Krajewska-Walasek M; McKee S; Smith J; Sweeney E; Mansour S; Mohammed S; Donnai D; Black G
    Am J Hum Genet; 2011 Nov; 89(5):675-81. PubMed ID: 22077973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xq25 duplication: the crucial role of the STAG2 gene in this novel human cohesinopathy.
    Leroy C; Jacquemont ML; Doray B; Lamblin D; Cormier-Daire V; Philippe A; Nusbaum S; Patrat C; Steffann J; Colleaux L; Vekemans M; Romana S; Turleau C; Malan V
    Clin Genet; 2016 Jan; 89(1):68-73. PubMed ID: 25677961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.
    Errichiello E; Mustafa N; Vetro A; Notarangelo LD; de Jonge H; Rinaldi B; Vergani D; Giglio SR; Morbini P; Zuffardi O
    J Pathol; 2017 Sep; 243(1):9-15. PubMed ID: 28608987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased STAG2 dosage defines a novel cohesinopathy with intellectual disability and behavioral problems.
    Kumar R; Corbett MA; Van Bon BW; Gardner A; Woenig JA; Jolly LA; Douglas E; Friend K; Tan C; Van Esch H; Holvoet M; Raynaud M; Field M; Leffler M; Budny B; Wisniewska M; Badura-Stronka M; Latos-Bieleńska A; Batanian J; Rosenfeld JA; Basel-Vanagaite L; Jensen C; Bienek M; Froyen G; Ullmann R; Hu H; Love MI; Haas SA; Stankiewicz P; Cheung SW; Baxendale A; Nicholl J; Thompson EM; Haan E; Kalscheuer VM; Gecz J
    Hum Mol Genet; 2015 Dec; 24(25):7171-81. PubMed ID: 26443594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay.
    Arboleda VA; Lee H; Dorrani N; Zadeh N; Willis M; Macmurdo CF; Manning MA; Kwan A; Hudgins L; Barthelemy F; Miceli MC; Quintero-Rivera F; Kantarci S; Strom SP; Deignan JL; ; Grody WW; Vilain E; Nelson SF
    Am J Hum Genet; 2015 Mar; 96(3):498-506. PubMed ID: 25728775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
    Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
    Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment.
    Hempel M; Cremer K; Ockeloen CW; Lichtenbelt KD; Herkert JC; Denecke J; Haack TB; Zink AM; Becker J; Wohlleber E; Johannsen J; Alhaddad B; Pfundt R; Fuchs S; Wieczorek D; Strom TM; van Gassen KL; Kleefstra T; Kubisch C; Engels H; Lessel D
    Am J Hum Genet; 2015 Sep; 97(3):493-500. PubMed ID: 26340335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SATB2-associated syndrome presenting with Rett-like phenotypes.
    Lee JS; Yoo Y; Lim BC; Kim KJ; Choi M; Chae JH
    Clin Genet; 2016 Jun; 89(6):728-32. PubMed ID: 26596517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo variants in the Helicase-C domain of CHD8 are associated with severe phenotypes including autism, language disability and overgrowth.
    An Y; Zhang L; Liu W; Jiang Y; Chen X; Lan X; Li G; Hang Q; Wang J; Gusella JF; Du Y; Shen Y
    Hum Genet; 2020 Apr; 139(4):499-512. PubMed ID: 31980904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.
    Dangiolo SB; Wilson A; Jobanputra V; Anyane-Yeboa K
    Am J Med Genet A; 2015 Dec; 167A(12):3161-6. PubMed ID: 26364555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the BAF-Complex Subunit DPF2 Are Associated with Coffin-Siris Syndrome.
    Vasileiou G; Vergarajauregui S; Endele S; Popp B; Büttner C; Ekici AB; Gerard M; Bramswig NC; Albrecht B; Clayton-Smith J; Morton J; Tomkins S; Low K; Weber A; Wenzel M; Altmüller J; Li Y; Wollnik B; Hoganson G; Plona MR; Cho MT; ; Thiel CT; Lüdecke HJ; Strom TM; Calpena E; Wilkie AOM; Wieczorek D; Engel FB; Reis A
    Am J Hum Genet; 2018 Mar; 102(3):468-479. PubMed ID: 29429572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.